Race Oncology (ASX:RAC) Insider Peter (Pete) Smith Buys 9,433 Shares

Race Oncology Limited (ASX:RAC) insider Peter (Pete) Smith bought 9,433 shares of the stock in a transaction dated Wednesday, November 26th. The shares were purchased at an average price of A$2.65 per share, for a total transaction of A$25,025.75.

Race Oncology Price Performance

The company has a market cap of $211.94 million, a P/E ratio of -14.60 and a beta of 1.74.

About Race Oncology

Race Oncology Limited, a clinical stage global biotechnology company, focuses on cancer care. Its lead product, bisantrene, is a small molecule anthracene chemotherapeutic. The company is developing bisantrene to address the unmet need of patients across multiple oncology indications, exploring anti-cancer plus cardio-protection.